Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2017 Filed Jun 9, 2017 17:06 UTC |
SICIGNANO HENRY IIIDirector · President and CEO
|
OtherWarrant to Purchase · Derivative | 300,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001140361-17-024590 · doc1.xml · derivative · entry 6 SICIGNANO HENRY III · CIK 0001508753 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 300,000 shares Expires 2017-11-09 Read SEC document |
| June 09, 2017 Filed Jun 9, 2017 17:06 UTC |
SICIGNANO HENRY IIIDirector · President and CEO
|
Tax withholdingCommon Stock | 98,631 | $1.83 | $180,001.58 |
DisclosureSEC source: 0001140361-17-024590 · doc1.xml · nonDerivative · entry 2 SICIGNANO HENRY III · CIK 0001508753 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,509,422 Read SEC document |
| June 09, 2017 Filed Jun 9, 2017 17:06 UTC |
SICIGNANO HENRY IIIDirector · President and CEO
|
OtherCommon Stock | 300,000 | $0.60 | $180,000.00 |
DisclosureSEC source: 0001140361-17-024590 · doc1.xml · nonDerivative · entry 1 SICIGNANO HENRY III · CIK 0001508753 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,608,053 F1 · kind: Mr. Sicignano exercised warrant shares via a cashless exercise. Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 17:04 UTC |
Moynihan Michael RobertVice President of R&D
|
SaleCommon Stock | 20,468 | $2.00 | $40,936.00 |
DisclosureSEC source: 0001140361-17-024587 · doc1.xml · nonDerivative · entry 1 Moynihan Michael Robert · CIK 0001508751 · Vice President of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 946,752 F1 · kind: Shares sold pursuant to predetermined criteria ($2.00 market price) contained in a Rule 10b5-1 trading plan instituted by the Reporting Person on October 26, 2015. Read SEC document |
| May 24, 2017 Filed May 26, 2017 16:30 UTC |
SULLIVAN NORA BDirector
|
GrantNon-Qualified Stock Option · Derivative | 100,000 | $1.39 Strike: $1.39 | $139,000.00 |
DisclosureSEC source: 0001140361-17-022564 · doc1.xml · derivative · entry 2 SULLIVAN NORA B · CIK 0001057067 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2022-05-24 F1 · derivative.exercise_date: Non-Qualified Stock Options which vest 100% on April 1, 2018. Read SEC document |
| May 24, 2017 Filed May 26, 2017 16:22 UTC |
SICIGNANO HENRY IIIDirector · President and CEO
|
GrantSock Option (Right to Buy) · Derivative | 333,000 | $1.39 Strike: $1.39 | $462,870.00 |
DisclosureSEC source: 0001140361-17-022548 · doc1.xml · derivative · entry 5 SICIGNANO HENRY III · CIK 0001508753 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,000 Underlying: Common Stock · 333,000 shares Expires 2027-05-24 F2 · derivative.exercise_date: Stock option grant which vests one-third on each of April 1, 2018, April 1, 2019 and April 1, 2020. Read SEC document |
| May 24, 2017 Filed May 26, 2017 16:25 UTC |
Moynihan Michael RobertVice President of R&D
|
GrantStock Option (Right to Buy) · Derivative | 62,000 | $1.39 Strike: $1.39 | $86,180.00 |
DisclosureSEC source: 0001140361-17-022555 · doc1.xml · derivative · entry 2 Moynihan Michael Robert · CIK 0001508751 · Vice President of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,000 Underlying: Common Stock · 62,000 shares Expires 2027-05-24 F1 · derivative.exercise_date: Stock option grant which vests one-third on each of April 1, 2018, April 1, 2019 and April 1. 2020. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:29 UTC |
SANDERS RICHARD M.Director
|
GrantNon-Qualified Stock Option · Derivative | 100,000 | $1.39 Strike: $1.39 | $139,000.00 |
DisclosureSEC source: 0001140361-17-022561 · doc1.xml · derivative · entry 2 SANDERS RICHARD M. · CIK 0001593976 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2022-05-24 F1 · derivative.exercise_date: Non-Qualified Stock Options which vest 100% on April 1, 2018. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:29 UTC |
Dunn Joseph ADirector
|
GrantNon-Qualified Stock Option · Derivative | 100,000 | $1.39 Strike: $1.39 | $139,000.00 |
DisclosureSEC source: 0001140361-17-022560 · doc1.xml · derivative · entry 2 Dunn Joseph A · CIK 0001522460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2022-05-24 F1 · derivative.exercise_date: Non-Qualified Stock Options which vest 100% on April 1, 2018. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:27 UTC |
Cornell James WDirector
|
GrantNon-Qualified Stock Option · Derivative | 100,000 | $1.39 Strike: $1.39 | $139,000.00 |
DisclosureSEC source: 0001140361-17-022558 · doc1.xml · derivative · entry 2 Cornell James W · CIK 0001523111 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2022-05-24 F1 · derivative.exercise_date: Non-Qualified Stock Options which vest 100% on April 1, 2018. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:26 UTC |
RUSHTON PAULVP of Plant Biotechnology
|
GrantStock Option (Right to Buy) · Derivative | 58,000 | $1.39 Strike: $1.39 | $80,620.00 |
DisclosureSEC source: 0001140361-17-022556 · doc1.xml · derivative · entry 1 RUSHTON PAUL · CIK 0001655330 · VP of Plant Biotechnology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,000 Underlying: Common Stock · 58,000 shares Expires 2027-05-24 F1 · derivative.exercise_date: Stock option grant which vests one-third on each of April 1, 2018, April 1, 2019 and April 1, 2020. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:24 UTC |
JAMES THOMAS L.VP, General Counsel & Sec'y.
|
GrantStock Option Grant (Right to Buy) · Derivative | 124,000 | $1.39 Strike: $1.39 | $172,360.00 |
DisclosureSEC source: 0001140361-17-022552 · doc1.xml · derivative · entry 2 JAMES THOMAS L. · CIK 0001608342 · VP, General Counsel & Sec'y. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,000 Underlying: Common Stock · 124,000 shares Expires 2027-05-24 F1 · derivative.exercise_date: Stock option grant which vests one-third on each of April 1, 2018, April 1, 2019 and April 1, 2020. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:23 UTC |
BRODFUEHRER JOHN TCFO & Treasurer
|
GrantStock Option (Right to Buy) · Derivative | 124,000 | $1.39 Strike: $1.39 | $172,360.00 |
DisclosureSEC source: 0001140361-17-022551 · doc1.xml · derivative · entry 2 BRODFUEHRER JOHN T · CIK 0001573515 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,000 Underlying: Common Stock · 124,000 shares Expires 2027-05-24 F1 · derivative.exercise_date: Stock option grant which vests one-third on each of April 1, 2018, April 1, 2019 and April 1, 2020. Read SEC document |
| May 15, 2017 Filed May 16, 2017 16:41 UTC |
SICIGNANO HENRY IIIDirector · President and CEO
|
OtherWarrant to Purchase · Derivative | 20,000 | $0.60 Strike: $0.60 | $12,000.00 |
DisclosureSEC source: 0001140361-17-021010 · doc1.xml · derivative · entry 6 SICIGNANO HENRY III · CIK 0001508753 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2017-05-15 F1 · kind: Warrants exercised for cash. Read SEC document |
| May 15, 2017 Filed May 16, 2017 16:41 UTC |
SICIGNANO HENRY IIIDirector · President and CEO
|
GiftCommon Stock | 4,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021010 · doc1.xml · nonDerivative · entry 3 SICIGNANO HENRY III · CIK 0001508753 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Custodian for Minor Child Disclosed balance after: 20,000 Read SEC document |
| May 15, 2017 Filed May 16, 2017 16:41 UTC |
SICIGNANO HENRY IIIDirector · President and CEO
|
GiftCommon Stock | 4,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-021010 · doc1.xml · nonDerivative · entry 2 SICIGNANO HENRY III · CIK 0001508753 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,308,053 Read SEC document |
| May 15, 2017 Filed May 16, 2017 16:41 UTC |
SICIGNANO HENRY IIIDirector · President and CEO
|
OtherCommon Stock | 20,000 | $0.60 | $12,000.00 |
DisclosureSEC source: 0001140361-17-021010 · doc1.xml · nonDerivative · entry 1 SICIGNANO HENRY III · CIK 0001508753 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,312,603 F1 · kind: Warrants exercised for cash. Read SEC document |
| March 31, 2017 Filed Mar 31, 2017 16:57 UTC |
Moynihan Michael RobertVice President of R&D
|
OtherWarrant to Purchase · Derivative | 150,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001140361-17-014209 · doc1.xml · derivative · entry 3 Moynihan Michael Robert · CIK 0001508751 · Vice President of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150,000 shares Expires 2017-05-15 Read SEC document |
| March 31, 2017 Filed Mar 31, 2017 16:57 UTC |
Moynihan Michael RobertVice President of R&D
|
Tax withholdingCommon Stock | 71,714 | $1.26 | $90,001.07 |
DisclosureSEC source: 0001140361-17-014209 · doc1.xml · nonDerivative · entry 2 Moynihan Michael Robert · CIK 0001508751 · Vice President of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 967,220 Read SEC document |
| March 31, 2017 Filed Mar 31, 2017 16:57 UTC |
Moynihan Michael RobertVice President of R&D
|
OtherCommon Stock | 150,000 | $0.60 | $90,000.00 |
DisclosureSEC source: 0001140361-17-014209 · doc1.xml · nonDerivative · entry 1 Moynihan Michael Robert · CIK 0001508751 · Vice President of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,038,934 F1 · kind: Mr. Moynihan exercised warrants via a cashless exercise prior to the Issuer's blackout period commencing April 1, 2017, in advance of the May 15, 2017 expiration date of the warrants. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 17:36 UTC |
Moynihan Michael RobertVice President of R&D
|
SaleCommon Stock | 100,000 | $1.28 | $128,060.00 |
DisclosureSEC source: 0001140361-16-084417 · doc1.xml · nonDerivative · entry 1 Moynihan Michael Robert · CIK 0001508751 · Vice President of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 888,934 F1 · kind: Shares sold pursuant to Rule 10b5-1 trading plan maintained by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were old in multiple transactions at prices ranging from $1.25 to $1.34, inclusive. The Reporting Person undertakes to provide 22nd Century Group, Inc., any security holder of 22nd Century Group, Inc., or the staff of the Securities & Exchange Commission, upon request, information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.